CD8A and neoplasm: Strikingly, no more distinct changes in tumor volume were found in tumor‐bearing mice lacking effective Cd8+ T cells, either in Rg5 monotherapy groups or the combination therapy group (Figure 7E), indicating that Cd8+ T cells are essential for the therapeutic effects of Rg5.